Form 4: Precigen CFO Harry Thomasian Jr. Granted 500,000 Stock Options

Harry Thomasian Jr., CFO of Precigen, Inc., was granted options to purchase 500,000 shares of common stock on May 31, 2024.

Summary

• On May 31, 2024, Harry Thomasian Jr., the Chief Financial Officer of Precigen, Inc. (PGEN), was granted an option to purchase 500,000 shares of the company's common stock.
• The exercise price of these options is $1.40 per share.
• The options vest 25% on May 31, 2025, and the remaining 75% vest in equal monthly installments over the subsequent three years.
• The options expire on May 31, 2034.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting a transaction. The sentiment is slightly positive as it indicates alignment of management's interests with shareholders through stock options.

Positives

• The granting of stock options to the CFO aligns his interests with those of the shareholders, incentivizing him to improve the company's performance.

Industry Context

Stock option grants are a common practice in the biotechnology industry to incentivize executives and align their interests with those of shareholders.

Stakeholder Impact

• Shareholders may view the granting of stock options positively as it incentivizes the CFO to increase shareholder value.

Key Dates